HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klepetko, W. Articles by Wolner, E. Search for Related Content PubMed PubMed Citation Articles by Klepetko, W. Articles by Wolner, E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 1048-1058, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application

W Klepetko, A Lohninger, W Wisser, MR Mueller, G Khunl-Brady, A Windisch, F Eckersberger and E Wolner
Department of Experimental Surgery, University of Vienna, Austria.

Pulmonary surfactant during lung transplantation was investigated in the control group of a canine single lung transplantation model by measuring dipalmitoyl-phosphatidylcholine, the main phosphocholine fraction of surfactant in bronchoalveolar lavage. In a second group of dogs, L-carnitine, an essential cofactor for transfer of long-chain fatty acids into the mitochondria, was applied. Organ function after pulmonary artery flushing with modified Euro-Collins solution and hypothermic storage for 4 hours was adequate in both groups, with significantly higher arterial oxygen pressure levels in the L-carnitine group after 12 (p less than 0.05) and 24 (p less than 0.025) hours, respectively. In the control group, a reduction of the dipalmitoyl- phosphotidylcholine portion on total phosphotidylcholines was observed 4 and 12 hours after transplantation of the left lung (p less than 0.005 and p less than 0.01, respectively, both specified by Student's t test for dependent data, not significant by Bonferroni correction). In the simultaneously stored right lungs, a constant fall of the dipalmitoyl-phosphotidylcholine portion was demonstrated. In the L- carnitine group, significantly higher dipalmitoyl-phosphotidylcholine levels were observed in the transplanted left lungs after 4 hours (p less than 0.01) and in the continuously stored right lungs after 24 hours (p less than 0.005), when compared with the control group. These results suggest that dipalmitoyl-phosphotidylcholine portion on total phosphotidylcholine decreases parallel to the extent of the ischemic damage. Furthermore, the application of L-carnitine improved pulmonary function after transplantation, possibly by reducing the impairing effect of ischemia on alveolar type II cell metabolism and thereby on pulmonary surfactant system.

This article has been cited by other articles:

				E. Koletsis, A. Chatzimichalis, V. Fotopoulos, K. Kokkinis, E. Papadimitriou, D. Tiniakos, E. Marinos, I. Bellenis, and D. Dougenis Donor Lung Pretreatment with Surfactant in Experimental Transplantation Preserves Graft Hemodynamics and Alveolar Morphology Exp Biol Med, May 1, 2003; 228(5): 540 - 545. [Abstract] [Full Text] [PDF]

				H. B. Srinivasan, S. M. Vogel, D. Vidyasagar, and A. B. Malik Protective effect of lung inflation in reperfusion-induced lung microvascular injury Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H951 - H957. [Abstract] [Full Text] [PDF]

				J. M. HOHLFELD, E. TIRYAKI, H. HAMM, H. G. HOYMANN, N. KRUG, A. HAVERICH, and H. FABEL Pulmonary Surfactant Activity Is Impaired in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 706 - 712. [Abstract] [Full Text] [PDF]

				A. Watanabe, N. Kawaharada, K. Kusajima, S. Komatsu, T. Abe, and H. Takahashi INFLUENCE OF OXYGEN IN INFLATION GAS DURING LUNG ISCHEMIA ON ISCHEMIA-REPERFUSION INJURY J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 332 - 338. [Abstract] [Full Text]

				S. A. Buchanan, M. C. Mauney, V. I. Parekh, N. F. DeLima, O. A. R. Binns, J. T. Cope, K. S. Shockey, C. G. Tribble, and I. L. Kron Intratracheal Surfactant Administration Preserves Airway Compliance During Lung Reperfusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1617 - 1621. [Abstract] [Full Text]

				M. Struber, J. Cremer, W. Harringer, S. W. Hirt, A. Costard-Jackle, and A. Haverich NEBULIZED SYNTHETIC SURFACTANT IN REPERFUSION INJURY AFTER SINGLE LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 563 - 564. [Full Text]

				R. J. Novick, F. Possmayer, R. A. W. Veldhuizen, A. H. Menkis, and F. N. McKenzie Surfactant analysis and replacement therapy: A future tool of the lung transplant surgeon? Ann. Thorac. Surg., November 1, 1991; 52(5): 1194 - 1200. [Abstract] [PDF]